Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 276

Similar articles for PubMed (Select 16309366)

1.

SELDI-TOF-MS proteomics of breast cancer.

Clarke CH, Buckley JA, Fung ET.

Clin Chem Lab Med. 2005;43(12):1314-20. Review.

PMID:
16309366
2.

Clinical proteomics in breast cancer: a review.

Gast MC, Schellens JH, Beijnen JH.

Breast Cancer Res Treat. 2009 Jul;116(1):17-29. doi: 10.1007/s10549-008-0263-3. Epub 2008 Dec 11. Review.

PMID:
19082706
4.

[Proteomics and breast cancer].

Mathelin C, Tomasetto C, Cromer A, Rio MC.

Gynecol Obstet Fertil. 2006 Dec;34(12):1161-9. Epub 2006 Nov 22. Review. French.

PMID:
17123853
6.

SELDI-TOF serum proteomics and breast cancer: which perspective?

Garrisi VM, Abbate I, Quaranta M, Mangia A, Tommasi S, Paradiso A.

Expert Rev Proteomics. 2008 Dec;5(6):779-85. doi: 10.1586/14789450.5.6.779. Review.

PMID:
19086858
7.

Clinical proteomics: searching for better tumour markers with SELDI-TOF mass spectrometry.

Engwegen JY, Gast MC, Schellens JH, Beijnen JH.

Trends Pharmacol Sci. 2006 May;27(5):251-9. Epub 2006 Apr 4. Review.

PMID:
16600386
8.

Advances in clinical cancer proteomics: SELDI-ToF-mass spectrometry and biomarker discovery.

Seibert V, Ebert MP, Buschmann T.

Brief Funct Genomic Proteomic. 2005 May;4(1):16-26. Review.

9.

[Proteomic profiling: the potential of Seldi-Tof for the identification of new cancer biomarkers].

Solassol J, Marin P, Maudelonde T, Mangé A.

Bull Cancer. 2005 Sep;92(9):763-8. Review. French.

PMID:
16203265
10.

Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer.

Li J, Zhang Z, Rosenzweig J, Wang YY, Chan DW.

Clin Chem. 2002 Aug;48(8):1296-304.

11.

SELDI-TOF proteomic analysis and cancer detection.

Henderson NA, Steele RJ.

Surgeon. 2005 Dec;3(6):383-90, 422. Review.

PMID:
16353858
12.

The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification.

Issaq HJ, Veenstra TD, Conrads TP, Felschow D.

Biochem Biophys Res Commun. 2002 Apr 5;292(3):587-92.

PMID:
11922607
13.

Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry.

Navaglia F, Fogar P, Basso D, Greco E, Padoan A, Tonidandel L, Fadi E, Zambon CF, Bozzato D, Moz S, Seraglia R, Pedrazzoli S, Plebani M.

Clin Chem Lab Med. 2009;47(6):713-23. doi: 10.1515/CCLM.2009.158.

PMID:
19426140
14.

Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease.

Zinkin NT, Grall F, Bhaskar K, Otu HH, Spentzos D, Kalmowitz B, Wells M, Guerrero M, Asara JM, Libermann TA, Afdhal NH.

Clin Cancer Res. 2008 Jan 15;14(2):470-7. doi: 10.1158/1078-0432.CCR-07-0586.

15.

SELDI-TOF serum proteomics and colorectal cancer: a current overview.

Gemoll T, Roblick UJ, Auer G, Jörnvall H, Habermann JK.

Arch Physiol Biochem. 2010 Oct-Dec;116(4-5):188-96. doi: 10.3109/13813455.2010.495130. Epub 2010 Jul 8. Review.

PMID:
20615064
16.

[Surface enhanced laser desorption/ionization (SELDI): proteomics technology and its application in oncology].

Espejel F, Roa JC.

Med Clin (Barc). 2008 Sep 13;131(8):312-7. Review. Spanish.

PMID:
18803927
17.

[Proteic profiling SELDI-TOF and breast cancer: clinical potential applications].

Gonçalves A, Bertucci F, Birnbaum D, Borg JP.

Med Sci (Paris). 2007 Mar;23 Spec No 1:23-6. Review. French.

18.

[Diagnostic application of serum protein pattern and artificial neural network software in breast cancer].

Hu Y, Zhang SZ, Yu JK, Liu J, Zheng S, Hu X.

Ai Zheng. 2005 Jan;24(1):67-71. Chinese.

PMID:
15642203
20.

Surface-enhanced laser desorption/ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node-negative breast cancer tumors.

Ricolleau G, Charbonnel C, Lodé L, Loussouarn D, Joalland MP, Bogumil R, Jourdain S, Minvielle S, Campone M, Déporte-Fety R, Campion L, Jézéquel P.

Proteomics. 2006 Mar;6(6):1963-75.

PMID:
16470659
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk